Literature DB >> 21936716

Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.

Connie J Sexton1, Elizabeth C Costenbader, Dang Thi Nhat Vinh, Pai Lien Chen, Tran Vu Hoang, Nguyen Thi Hoang Lan, Paul Feldblum, Andrea Kim, Le Truong Giang.   

Abstract

The primary aim of this study was to estimate HIV incidence within a high-risk population in Ho Chi Minh City (HCMC), Vietnam using both cross-sectional and prospective methodologies. A secondary aim was to develop a local correction factor for the BED and avidity index incidence assays. The research study design consisted of three phases: (1) cross-sectional, (2) prospective, and (3) BED false recent (BED FR). A total of 1619 high-risk, sexually active individuals were enrolled in the cross-sectional phase and 355 of the opiate-negative, HIV-negative women were subsequently enrolled in the prospective phase. Four-hundred and three men and women with known HIV infection duration of greater than 12 months were enrolled in the BED FR phase. The HIV prevalence for all participants in the cross-sectional phase was 15.8%. HIV incidence in the cross-sectional group was estimated using the BED IgG capture assay and AxSYM avidity index assay for recent HIV infection and incidence within the prospective cohort was determined by observations of HIV seroconversion. HIV incidence in opiate-negative women was estimated using the BED assay to be 0.8% unadjusted and 0.5% after applying the locally derived BED false recent rate of 1.7%; no seroconversions were observed in the prospective cohort. We also screened the cross-sectional samples for evidence of acute infection using nucleic acid testing, 4th generation HIV EIA, and SMARTube coupled with Genscreen and Determine diagnostic tests; no confirmed acute infections were identified by any method. HIV incidence within this opiate-negative study population was low and incidence estimates from the two methods compared favorably with each other. Incidence estimates and false recent rates using the AxSYM assay were higher: AI FRR of 2.7% and adjusted incidence of 1.7% per year (95% CI, 0.6, 2.8). By comparison, both HIV prevalence and incidence estimates for the opiate-positive group were higher.

Entities:  

Mesh:

Year:  2011        PMID: 21936716     DOI: 10.1089/aid.2011.0221

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.

Authors:  Li Yu; Oliver Laeyendecker; Sarah K Wendel; Fuxiong Liang; Wei Liu; Xueyan Wang; Lu Wang; Xianwu Pang; Zhongliao Fang
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-02       Impact factor: 2.205

2.  Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.

Authors:  Neha S Shah; Yen T Duong; Linh-Vi Le; Nguyen Anh Tuan; Bharat S Parekh; Hoang Thi Thanh Ha; Quang Duy Pham; Cao Thi Thu Cuc; Trudy Dobbs; Tran Hong Tram; Truong Thi Xuan Lien; Nick Wagar; Chunfu Yang; Amy Martin; Mitchell Wolfe; Nguyen Tran Hien; Andrea A Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-13       Impact factor: 2.205

3.  Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D.

Authors:  Andrew F Longosz; Charles S Morrison; Pai-Lien Chen; Hilmarie H Brand; Eric Arts; Immaculate Nankya; Robert A Salata; Thomas C Quinn; Susan H Eshleman; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-19       Impact factor: 2.205

4.  Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth.

Authors:  Ethan Obie Romero-Severson; Cody Lee Petrie; Edward Ionides; Jan Albert; Thomas Leitner
Journal:  Int J Epidemiol       Date:  2015-07-10       Impact factor: 7.196

5.  Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.

Authors:  Emmi Andersson; Wei Shao; Irene Bontell; Fatim Cham; Do Duy Cuong; Amogne Wondwossen; Lynn Morris; Gillian Hunt; Anders Sönnerborg; Silvia Bertagnolio; Frank Maldarelli; Michael R Jordan
Journal:  Infect Genet Evol       Date:  2013-04-11       Impact factor: 3.342

6.  Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan highlands.

Authors:  Jennifer C Stevenson; Gillian H Stresman; Caroline W Gitonga; Jonathan Gillig; Chrispin Owaga; Elizabeth Marube; Wycliffe Odongo; Albert Okoth; Pauline China; Robin Oriango; Simon J Brooker; Teun Bousema; Chris Drakeley; Jonathan Cox
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

Review 7.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.